{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "Coronavirus",
      "Emerging viruses",
      "Neumon\u00eda",
      "Pneumonia",
      "SARS-CoV-2",
      "Virus Emergentes",
      "Zoonosis"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [
    {
      "AbstractText": [
        "Los primeros casos de COVID-19, causada por el virus denominado SARS-CoV-2, se registraron en Wuhan, China, en diciembre de 2019; sin embargo, su capacidad de transmisi\u00f3n ocasion\u00f3 que seis meses despu\u00e9s la infecci\u00f3n pr\u00e1cticamente estuviera presente en todo el mundo. El origen del virus parece ser zoon\u00f3tico; se propone que proviene del murci\u00e9lago y podr\u00eda haber tenido un hospedero intermediario que llev\u00f3 a su introducci\u00f3n en la poblaci\u00f3n humana. SARS-CoV-2 es un virus envuelto, con genoma de ARN de cadena sencilla en sentido positivo y se ancla a la enzima convertidora de angiotensina, presente en las c\u00e9lulas susceptibles para infectar el sistema respiratorio de los humanos. Aunque previamente se han conocido otros coronavirus, no han tenido el mismo impacto, por lo que la investigaci\u00f3n en tratamientos farmacol\u00f3gicos no tiene el desarrollo suficiente para afrontar el reto actual. Casi desde el comienzo de la epidemia se han propuesto mol\u00e9culas para el tratamiento de la infecci\u00f3n, sin embargo, a\u00fan no se cuenta con un f\u00e1rmaco con suficiente efectividad terap\u00e9utica. En esta revisi\u00f3n se describen las caracter\u00edsticas principales de SARS-CoV-2, su ciclo replicativo, su posible origen y algunos avances en el desarrollo de tratamientos antivirales."
      ],
      "CopyrightInformation": "Copyright: \u00a9 2020 Permanyer."
    }
  ],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34125824",
  "DateCompleted": {
    "Year": "2021",
    "Month": "07",
    "Day": "08"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.24875/GMM.M21000524"
    ],
    "Journal": {
      "ISSN": "0016-3813",
      "JournalIssue": {
        "Volume": "157",
        "Issue": "1",
        "PubDate": {
          "Year": "2021"
        }
      },
      "Title": "Gaceta medica de Mexico",
      "ISOAbbreviation": "Gac Med Mex"
    },
    "ArticleTitle": "SARS-CoV-2: basic concepts, origin and treatment advances.",
    "Pagination": {
      "StartPage": "84",
      "EndPage": "89",
      "MedlinePgn": "84-89"
    },
    "Abstract": {
      "AbstractText": [
        "The first cases of COVID-19, caused by the virus called SARS-CoV-2, were recorded in Wuhan, China, in December 2019; however, its transmission ability caused for the infection to be practically present throughout the world six months later. The origin of the virus appears to be zoonotic; it has been proposed that it comes from a bat and that it may have had an intermediate host that led to its introduction in the human population. SARS-CoV-2 is an enveloped virus, with a positive single-stranded RNA genome, and it binds to the angiotensin-converting enzyme, present in susceptible cells, to infect the human respiratory system. Although other coronaviruses have been previously known, they have not had the same impact, and, therefore, research on pharmacological treatments is not sufficiently developed to face the current challenge. Almost since the beginning of the epidemic, several molecules have been proposed for the treatment of infection; however, there is not yet a drug available with sufficient effectiveness for treatment. This review describes SARS-CoV-2 main characteristics, its replicative cycle, its possible origin and some advances in the development of antiviral treatments."
      ],
      "CopyrightInformation": "Copyright: \u00a9 2020 Permanyer."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Instituto Mexicano del Seguro Social, Centro de Investigaci\u00f3n Biom\u00e9dica de Oriente, Puebla, Mexico."
          }
        ],
        "LastName": "Santos-L\u00f3pez",
        "ForeName": "Gerardo",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Instituto Mexicano del Seguro Social, Centro de Investigaci\u00f3n Biom\u00e9dica de Oriente, Puebla, Mexico."
          }
        ],
        "LastName": "Cort\u00e9s-Hern\u00e1ndez",
        "ForeName": "Paulina",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Instituto Mexicano del Seguro Social, Centro de Investigaci\u00f3n Biom\u00e9dica de Oriente, Puebla, Mexico."
          }
        ],
        "LastName": "Vallejo-Ruiz",
        "ForeName": "Ver\u00f3nica",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Instituto Mexicano del Seguro Social, Centro de Investigaci\u00f3n Biom\u00e9dica de Oriente, Puebla, Mexico."
          }
        ],
        "LastName": "Reyes-Leyva",
        "ForeName": "Julio",
        "Initials": "J"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ],
    "VernacularTitle": "SARS-CoV-2: generalidades, origen y avances en el tratamiento."
  },
  "MedlineJournalInfo": {
    "Country": "Mexico",
    "MedlineTA": "Gac Med Mex",
    "NlmUniqueID": "0010333",
    "ISSNLinking": "0016-3813"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "physiology",
        "ultrastructure"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ]
}